| Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease LB Travis, DA Hill, GM Dores, M Gospodarowicz, FE Van Leeuwen, ... Jama 290 (4), 465-475, 2003 | 670 | 2003 |
| Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease LB Travis, DA Hill, GM Dores, M Gospodarowicz, FE Van Leeuwen, ... Jama 290 (4), 465-475, 2003 | 670 | 2003 |
| Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease LB Travis, M Gospodarowicz, RE Curtis, E Aileen Clarke, M Andersson, ... Journal of the National Cancer Institute 94 (3), 182-192, 2002 | 571 | 2002 |
| Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma D Molin, A Edström, I Glimelius, B Glimelius, G Nilsson, C Sundström, ... British journal of haematology 119 (1), 122-124, 2002 | 213 | 2002 |
| Angiogenesis and mast cells in Hodgkin lymphoma I Glimelius, A Edström, M Fischer, G Nilsson, C Sundström, D Molin, ... Leukemia 19 (12), 2360-2362, 2005 | 48 | 2005 |
| The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma–a Swedish population-based study M Mohammadi, Y Cao, I Glimelius, M Bottai, S Eloranta, KE Smedby BMC cancer 15 (1), 1-12, 2015 | 46 | 2015 |
| IL‐9 expression contributes to the cellular composition in Hodgkin lymphoma I Glimelius, A Edström, RM Amini, M Fischer, G Nilsson, C Sundström, ... European journal of haematology 76 (4), 278-283, 2006 | 41 | 2006 |
| Novel treatment concepts in Hodgkin lymphoma I Glimelius, A Diepstra Journal of internal medicine 281 (3), 247-260, 2017 | 37 | 2017 |
| Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB I Glimelius, D Molin, RM Amini, A Gustavsson, B Glimelius, G Enblad European journal of haematology 71 (5), 327-333, 2003 | 36 | 2003 |
| Long‐term survival in young and middle‐aged H odgkin lymphoma patients in S weden 1992–2009—trends in cure proportions by clinical characteristics I Glimelius, S Ekberg, M Jerkeman, ET Chang, M Björkholm, ... American journal of hematology 90 (12), 1128-1134, 2015 | 35 | 2015 |
| Autoimmune and atopic disorders and risk of classical Hodgkin lymphoma P Hollander, K Rostgaard, KE Smedby, ET Chang, RM Amini, ... American journal of epidemiology 182 (7), 624-632, 2015 | 35 | 2015 |
| Pregnancy and the risk of relapse in patients diagnosed with Hodgkin lymphoma CE Weibull, S Eloranta, KE Smedby, M Björkholm, SY Kristinsson, ... Journal of Clinical Oncology 34 (4), 337-344, 2016 | 31 | 2016 |
| Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time—a population-based comparative study I Glimelius, S Ekberg, J Linderoth, M Jerkeman, ET Chang, M Neovius, ... Journal of cancer survivorship 9 (4), 599-609, 2015 | 31 | 2015 |
| Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis A Monnereau, SL Glaser, CW Schupp, K Ekström Smedby, S de Sanjosé, ... Blood 122 (20), 3492-3499, 2013 | 31 | 2013 |
| The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma G Enblad, D Molin, I Glimelius, M Fischer, G Nilsson Hematology/oncology clinics of North America 21 (5), 805-823, 2007 | 31 | 2007 |
| The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence R Troisi, T Bjørge, M Gissler, T Grotmol, CM Kitahara, SM Myrtveit Saether, ... Journal of internal medicine 283 (5), 430-445, 2018 | 30 | 2018 |
| High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome P Hollander, P Kamper, KE Smedby, G Enblad, M Ludvigsen, ... Blood advances 1 (18), 1427-1439, 2017 | 27 | 2017 |
| Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin’s Lymphoma–a population‐based study I Glimelius, J Rubin, K Rostgaard, RM Amini, M Simonsson, KM Sorensen, ... European journal of haematology 87 (3), 208-216, 2011 | 26 | 2011 |
| Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines I Glimelius, J Rubin, M Fischer, D Molin, RM Amini, P Venge, G Enblad Experimental hematology 39 (8), 850-858, 2011 | 20 | 2011 |
| Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma—A population‐based study from Sweden M Björkholm, CE Weibull, S Eloranta, KE Smedby, I Glimelius, ... European journal of haematology 101 (1), 106-114, 2018 | 18 | 2018 |
Sandra ElorantaClinical Epidemiology Unit, Department of Medicine, Karolinska InstitutetVerified email at ki.se
